Gesundheit Österreich GmbH - Geschäftsbereich ÖBIG
PPRI -
Pharmaceutical Pricing and Reimbursement Information
banner GÖG/ÖBIG BMG EU WHO

Since October 2011 the PPRI website is no longer maintained.

Please refer from now on to the website of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies: http://whocc.goeg.at.

Country reports

The PPRI Pharma Profiles are country specific reports on health and pharmaceutical systems, with a special focus on pricing, reimbursement and rational use of pharmaceuticals. The PPRI Pharma Profiles were written by country experts, often involved in pricing and reimbursement decisions, and were reviewed by an experienced editorial team.

In producing the PPRI Pharma Profiles, the authors have been committed to using a common uniform terminology defined in the PPRI Glossary.

The PPRI Pharma Profiles are intended to be regularly updated, depending on the resources each country has available. In addition, the countries are currently writing on an integrated PHIS Pharma Profile covering pricing and reimbursement information of medicines in the in- and the out-patient sector. More information can be obtained from the PHIS website (http://phis.goeg.at).

Albania
PPRI Pharma Profile Albania, 2009
Austria
PPRI Pharma Profile Austria, 2008, German version
PPRI Pharma Profile Austria, 2008, English version
PPRI Pharma Profile Austria, 2007
Belgium
PPRI Pharma Profile Belgium, 2008
PPRI Pharma Profile Belgium, 2007
Bulgaria
PPRI Pharma Profile Bulgaria, 2007
Czech Republic
Cyprus
PPRI Pharma Profile Cyprus, 2007
Denmark
PPRI Pharma Profile Denmark, 2007
Estonia
PPRI Pharma Profile Estonia, 2007
Finland
PPRI Pharma Profile Finland, 2007
France
PPRI Pharma Profile France, 2008
PPRI Pharma Profile France, 2007
PPRI Pharma Profile France, 2007, Korean version
Germany
PPRI Pharma Profile Germany, 2008
Greece
PPRI Pharma Profile Greece, 2007
Hungary
PPRI Pharma Profile Hungary, 2007
Ireland
PPRI Pharma Profile Ireland, 2007
Italy
PPRI Pharma Profile Italy, 2007
Latvia
PPRI Pharma Profile Latvia, 2008
PPRI Pharma Profile Latvia, 2007
Lithuania
PPRI Pharma Profile Lithuania, 2008
PPRI Pharma Profile Lithuania, 2007
Luxembourg
Malta
Netherlands
Norway
PPRI Pharma Profile Norway, 2008
PPRI Pharma Profile Norway, 2007
Poland
PPRI Pharma Profile Poland, 2007
Portugal
PPRI Pharma Profile Portugal, 2008
Slovakia
PPRI Pharma Profile Slovakia, 2007
Slovenia
Spain
A brief PPRI Pharma Profile on Spain and an updated comparative analysis incl. Spain is provided in an article published in Pharmaceuticals Policy and Law 11 (2009) 213–234.
Please download the article on Spain here.
Sweden
PPRI Pharma Profile Sweden, 2007
Turkey
PPRI Pharma Profile Turkey, 2007
United Kingdom
PPRI Pharma Profile United Kingdom, 2007
PPRI Pharma Profile United Kingdom, 2007, Korean version

The PPRI Pharma Profiles are based on a uniform structure, the so-called PPRI Pharma Profile Template, which allows for comparability. Researchers and further interested persons and institutions are encouraged to use the PPRI Pharma Profiles (see also the Disclaimer); please quote the used information (PPRI Report, PPRI Pharma Profiles as well as for all other documents in the section Concise information) correctly. When you use PPRI information we would appreciate if you could leave a message at the PPRI Secretariat.

All PPRI Pharma Profiles contain a 1-page flowchart on the pharmaceutical systems.